Home / Current Issue / Paper 1723737
Patient-Level Deep Fusion, Radiomics, and Ensemble Learning for CT-Based Differentiation of Multiple Primary Lung Cancers
Subject area: Science,Engineering and Technology · Area of research: Machine Learning, Deep Learning, Medical Image
Abstract
Background: Multiple primary lung cancers (MPLCs) are increasingly detected owing to advances in chest computed tomography (CT), yet distinguishing them from intrapulmonary metastases (IPMs) and multiple benign pulmonary lesions (MBPLs) remains difficult and strongly affects treatment planning. Methods: We propose a patient-level framework that combines (i) a deep fusion network integrating 2D multiple-instance learning (2D-MIL) over axial slices, a 3D volumetric branch, and handcrafted radiomic features, with (ii) radiomics-based Random Forest and XGBoost classifiers, and (iii) a soft-voting ensemble of these models. Performance was assessed with accuracy, precision, recall, F1-score, specificity, and the area under the receiver operating characteristic curve (ROC-AUC). Results: On the held-out test set, the radiomics-based XGBoost model achieved the highest ROC-AUC (0.9782), while Random Forest and XGBoost both reached an accuracy of 0.8571 and a precision of 0.9091. The deep fusion model obtained an accuracy of 0.7143 and an ROC-AUC of 0.9154, and the ensemble obtained an accuracy of 0.7619 and an ROC-AUC of 0.9376. Conclusions: Radiomics-driven tree-based models were the most discriminative in this cohort, whereas the deep fusion model and ensemble were competitive in ROC-AUC but weaker in threshold-dependent metrics. Validation on larger, multicenter cohorts is required.
Keywords
ensemble learning; multiple primary lung cancer; intrapulmonary metastasis; CT; radiomics; deep learning; multiple-instance learning
References
[1] Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2021;71:209–249. https://doi.org/10.3322/caac.21660
[2] Wang YL, Wang YG. Current status and prospects of multiple primary lung cancer research. Chin. J. Cancer Prev. Treat. 2019;26(9):670–674.
[3] Yuan L, et al. The advancement of predictive diagnosis and molecular mechanism in multiple primary lung cancer. Chin. J. Cancer. 2010;29(5):575–578. https://doi.org/10.5732/cjc.009.10282
[4] Li R, Li X, Xue R, et al. Diagnosis and management of multiple primary lung cancer. J. Thorac. Dis. 2024;16(10):6039–6051. https://doi.org/10.21037/jtd-23-1645
[5] Wang Z, Wang S, Chang C, et al. Multiple primary lung cancer: Updates and perspectives. Int. J. Cancer. 2024;155(2):193–207. https://doi.org/10.1002/ijc.34994
[6] Zhang Z, Zhang Y, Feng A, et al. Multiple primary lung cancer: Updates of clinical management and challenges. Front. Oncol. 2023;13:1034752. https://doi.org/10.3389/fonc.2023.1034752
[7] Kozower BD, Larner JM, Detterbeck FC, Jones DR. Special treatment issues in non-small cell lung cancer: Diagnosis and management of lung cancer, American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5):e369S–e399S. https://doi.org/10.1378/chest.12-2362
[8] Girard N, et al. Comprehensive histologic assessment helps to differentiate multiple lung primary nonsmall cell carcinomas from metastases. Am. J. Surg. Pathol. 2009;33:1752–1764. https://doi.org/10.1097/PAS.0b013e3181b8cf03
[9] Huang M, Xu Q, Zhou M, Li X, Lv W, Zhou C, et al. Distinguishing multiple primary lung cancers from intrapulmonary metastasis using CT-based radiomics. Eur. J. Radiol. 2023;160:110671. https://doi.org/10.1016/j.ejrad.2022.110671
[10] Chen TF, Yang L, Chen HB, Zhou ZG, Wu ZT, Luo HH, et al. A pairwise radiomics algorithm–lesion pair relation estimation model for distinguishing multiple primary lung cancer from intrapulmonary metastasis. Precis. Clin. Med. 2023;6(4):pbad029. https://doi.org/10.1093/pcmedi/pbad029
[11] Astaraki M, Yang G, Zakko Y, Toma-Dasu I, Smedby I, Wang C. A comparative study of radiomics and deep-learning based methods for pulmonary nodule malignancy prediction in low dose CT images. Front. Oncol. 2021;11:737368. https://doi.org/10.3389/fonc.2021.737368
[12] Suh YJ, Lee HJ, Sung PS, Kim MS, Lee JG, Park S, et al. A novel algorithm to differentiate between multiple primary lung cancers and intrapulmonary metastasis in multiple lung cancers with multiple pulmonary sites of involvement. J. Thorac. Oncol. 2020;15(2):203–215. https://doi.org/10.1016/j.jtho.2019.09.221
[13] Shao L, Wang XD, Wu PY, Zhang JQ, Liu LX, Wu CL, et al. A comprehensive algorithm to distinguish between MPLC and IPM in multiple lung tumors patients. Ann. Transl. Med. 2020;8(18):1137. https://doi.org/10.21037/atm-20-5505
[14] Liufu Y, Su R, Wen Y, Guan Y, Mahmoud MA. A CT-based deep learning approach to differentiate multiple primary lung cancers, metastases, and benign nodules. BMC Cancer. 2026;26:177. https://doi.org/10.1186/s12885-025-15501-1
[15] Gayap HT, Akhloufi MA. Deep machine learning for medical diagnosis, application to lung cancer detection: A review. BioMedInformatics. 2024;4(1):236–284. https://doi.org/10.3390/biomedinformatics4010015
[16] Atmakuru A, Chakraborty S, Faust O, Salvi M, Barua PD, Molinari F, et al. Deep learning in radiology for lung cancer diagnostics: A systematic review of classification, segmentation, and predictive modeling techniques. Expert Syst. Appl. 2024;255:124665. https://doi.org/10.1016/j.eswa.2024.124665
[17] He K, Zhang X, Ren S, Sun J. Deep residual learning for image recognition. In: Proc. IEEE Conf. Comput. Vis. Pattern Recognit. (CVPR). 2016. p. 770–778. https://doi.org/10.1109/CVPR.2016.90
[18] Huang G, Liu Z, van der Maaten L, Weinberger KQ. Densely connected convolutional networks. In: Proc. IEEE Conf. Comput. Vis. Pattern Recognit. (CVPR). 2017. p. 4700–4708. https://doi.org/10.1109/CVPR.2017.243
[19] Tan M, Le Q. EfficientNet: Rethinking model scaling for convolutional neural networks. In: Proc. Int. Conf. Mach. Learn. (ICML). 2019. p. 6105–6114.
[20] Dosovitskiy A, et al. An image is worth 16×16 words: Transformers for image recognition at scale. arXiv preprint arXiv:2010.11929. 2020. https://doi.org/10.48550/arXiv.2010.11929
[21] Liu Z, Hu H, Lin Y, Yao Z, Xie Z, Wei Y, et al. Swin Transformer V2: Scaling up capacity and resolution. In: Proc. IEEE/CVF Conf. Comput. Vis. Pattern Recognit. (CVPR). 2022. p. 12009–12019. https://doi.org/10.1109/CVPR52688.2022.01170
[22] Yu W, Wang X. MambaOut: Do we really need Mamba for vision? In: Proc. IEEE/CVF Conf. Comput. Vis. Pattern Recognit. (CVPR). 2025. p. 4484–4496. https://doi.org/10.1109/CVPR52734.2025.00423
[23] Ilse M, Tomczak JM, Welling M. Attention-based deep multiple instance learning. In: Proc. Int. Conf. Mach. Learn. (ICML). 2018. p. 2127–2136. https://doi.org/10.48550/arXiv.1802.04712
[24] Breiman L. Random forests. Mach. Learn. 2001;45(1):5–32. https://doi.org/10.1023/A:1010933404324
[25] Chen T, Guestrin C. XGBoost: A scalable tree boosting system. In: Proc. 22nd ACM SIGKDD Int. Conf. Knowl. Discov. Data Min. 2016. p. 785–794. https://doi.org/10.1145/2939672.2939785
[26] van Griethuysen JJM, Fedorov A, Parmar C, et al. Computational radiomics system to decode the radiographic phenotype. Cancer Res. 2017;77(21):e104–e107. https://doi.org/10.1158/0008-5472.CAN-170339
[27] Vickers AJ, Elkin EB. Decision curve analysis: A novel method for evaluating prediction models. Med. Decis. Making. 2006;26(6):565–574. https://doi.org/10.1177/0272989X06295361
[28] Selvaraju RR, Cogswell A, Das A, Vedantam R, Parikh D, Batra D. Grad-CAM: Visual explanations from deep networks via gradient-based localization. Int. J. Comput. Vis. 2020;128(2):336–359. https://doi.org/10.1007/s11263-019-01228-7
How to cite this paper
@article{1723737,
author = {Arnab Dutta},
title = {Patient-Level Deep Fusion, Radiomics, and Ensemble Learning for CT-Based Differentiation of Multiple Primary Lung Cancers},
journal = {Iconic Research And Engineering Journals},
year = {2026},
volume = {10},
number = {4},
pages = {838-855},
issn = {2456-8880},
url = {https://www.irejournals.com/formatedpaper/1723737.pdf},
abstract = {Background: Multiple primary lung cancers (MPLCs) are increasingly detected owing to advances in chest computed tomography (CT), yet distinguishing them from intrapulmonary metastases (IPMs) and multiple benign pulmonary lesions (MBPLs) remains difficult and strongly affects treatment planning.
Methods: We propose a patient-level framework that combines (i) a deep fusion network integrating 2D multiple-instance learning (2D-MIL) over axial slices, a 3D volumetric branch, and handcrafted radiomic features, with (ii) radiomics-based Random Forest and XGBoost classifiers, and (iii) a soft-voting ensemble of these models. Performance was assessed with accuracy, precision, recall, F1-score, specificity, and the area under the receiver operating characteristic curve (ROC-AUC).
Results: On the held-out test set, the radiomics-based XGBoost model achieved the highest ROC-AUC (0.9782), while Random Forest and XGBoost both reached an accuracy of 0.8571 and a precision of 0.9091. The deep fusion model obtained an accuracy of 0.7143 and an ROC-AUC of 0.9154, and the ensemble obtained an accuracy of 0.7619 and an ROC-AUC of 0.9376.
Conclusions: Radiomics-driven tree-based models were the most discriminative in this cohort, whereas the deep fusion model and ensemble were competitive in ROC-AUC but weaker in threshold-dependent metrics. Validation on larger, multicenter cohorts is required.},
keywords = {ensemble learning; multiple primary lung cancer; intrapulmonary metastasis; CT; radiomics; deep learning; multiple-instance learning},
month = {October},
}